A simplified technique for determining the sensitivity of cytomegalovirus strains to ganciclovir

Journal of Virological Methods

Volumn 60, Issue 1, 1996, Pages 59-64

  Calico I ^a,b   Balada, E ^a,c   Borra, A Cortés ^a   Mercader, E ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE   (Spain)

^c NONE   (United States)

Author keywords

CMV resistant strain; Cytomegalovirus; Ganciclovir susceptibility

Indexed keywords

GANCICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; DRUG RESISTANCE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0029936352     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(96)02045-9     Document Type: Article

References (12)

1. Cohen, A.T., O'Grady, J.G., Sutherland, S., Sallie, R., Tan, K.C. and Williams, R. (1993) Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J. Med. Virol. 40, 5-9.
2. Cunningham, C.H. (1973) Some statistical methods in virus studies. In: C.H. Cunningham (ed.). A Laboratory Guide in Virology. 7th edn. Ed Burgess Publishing. MN., pp. 65-73.
3. Dieterich, D.T., Poles, M.A., Lew, L.A., Mendez, P.E., Murphy, R., Addessi, A., Holbrook, J.T., Naughton, K. and Friedberg, D.N. (1993) Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J. Infect. Dis. 167, 1184-1188.
4. Drew, W.L. and Matthews, T.R. (1989) Susceptibility testing of herpes viruses. Clin. Lab. Med. 9, 279-286.
5. Erice, A., Chou, S., Biron, K.K., Stanat, S.C., Balfour, H.H. Jr. and Jordan, M.C. (1989) Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N. Engl. J. Med. 320, 289-293.
6. Hirsch, M.S. and Schooley, R.T. (1989) Resistance to antiviral drugs: the end of innocence. N. Engl. J. Med. 320, 313-314.
7. Pepin, J.M., Simon, F., Dussault, A., Collin, G., Dazza, M.C. and Brun-Vezinet, F. (1992) Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J. Clin. Microbiol. 30, 2917-2920.
8. Plotkin, S.A., Drew, W.L., Felsenstein, D. and Hirsch, M.S. (1985) Susceptibility of clinical isolates of human cytomegalovirus to 9-(1,3-Dihydroxy-2-propoxymethyl) guanine. J. Infect. Dis. 152, 833-834.
9. Razis, E., Cook, P., Mittelman, A. and Ahmed, T. (1994) Treatment of ganciclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantation. Leuk. Lymph. (Switzerland) 12, 477-480.
10. Tatarowicz, W.A., Lurain N.S. and Thompson, K.D. (1992) A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J. Infect. Dis. 166, 904-907.
11. Tokumoto, J.I. and Hollander, H. (1993) Cytomegalovirus polyradiculopathy caused by a ganciclovir-resistant strain. Clin. Infect. Dis. 17, 854-856.
12. Walmsley, S.L., Chew, E., Read, S.E., Vellend, H., Salit, I., Rachlis, A. and Fanning, M.M. (1988) Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet). J. Infect. Dis. 157, 569-572.